| New Guidelines: Diagnosis, Treatment and Medications Across Mental and Medical Therapeutic Areas |
| From the Psychiatry and Behavioral Health Section held August 5, 2016 at the 113th NMA Annual Convention and Scientific Assembly in Detroit, MI |
| William D. Richie, M.D – Moderator |
| Faculty: |
| William B. Lawson, M.D., Ph.D. Schizophrenia New Paradigms: “First Episode” and “Community Treatment:” Using Long-Acting Injectable Antipsychotic Medications to Reduce Relapse and Hospitalizations |
| Rahn Kennedy Bailey, M.D. Assessing Schizophrenia Medications: Review of Benefits and Risks for Managing Long-Acting Injectable Antipsychotics in Community Practices |
| Annelle B. Primm, M.D., M.P.H. Managing Common Medical Comorbidities in People with Schizophrenia |
| Please click here to download a PDF copy of the course book. |
